HPTN Publications

Adimora AA, Ramirez C, Auerbach JD, Aral SO, Hodder S, Wingood G, El-Sadr W, Bukusi EA; HIV Prevention Trials Network Women at Risk Committee . Preventing HIV infection in women. J Acquir Immune Defic Syndr. 2013, 63: S168-73

Albert LM, Edwards J, Pence B, Speizer IS, Hillis S, Kahn K, Gomez-Olive FX, Wagner RG, Twine R, Pettifor A . Associations of Father and Adult Male Presence with First Pregnancy and HIV Infection: Longitudinal Evidence from Adolescent Girls and Young Women in Rural South Africa (HPTN 068). AIDS Behav. 2021, 25: 2177-2194

Amico KR, Mayer KH, Landovitz RJ, Marzinke M, Hendrix C, McCauley M, Wilkin T, Gulick R; HPTN 069/A5305 study team . Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study. AIDS Behav. 2024, 28: 1058-1067

Amico KR, Ramirez C, Caplan MR, Montgomery BE, Stewart J, Hodder S, Swaminathan S, Wang J, Darden-Tabb NY, McCauley M, Mayer KH, Wilkin T, Landovitz RJ, Gulick R, Adimora AA, HPTN 069/A5305 Study Team, HPTN Women at Risk Committee . Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions. J Int AIDS Soc. 2019, 22: e25247

Anderson PL, Marzinke MA, Glidden DV . Updating the adherence-response for oral F-TDF for PrEP among cisgender women. Clin Infect Dis. 2023, 76: 1850-1853

Aroke H, Buchanan A, Katenka N, Crawford FW, Lee T, Halloran ME, Latkin C . Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs. AIDS Behav. 2023, 27: 578-590

Avery LB, Sacktor N, McArthur JC, Hendrix CW . Protein-free efavirenz concentrations in cerebrospinal fluid & blood plasma are equivalent: Applying the law of mass action to predict protein-free drug concentration. Antimicrob Agents Chemother. 2013, 57: 1409-14

Baeten JM, Haberer JE, Liu AY, Sista N . Preexposure prophylaxis for HIV prevention: where have we been and where are we going?. J Acquir Immune Defic Syndr. 2013, 63: S122-9